Evidence map›Paper›PMID 35440781›Full record

ArticleNature biotechnology2022

Author Correction: Development of spirulina for the manufacture and oral delivery of protein therapeutics.

Benjamin W Jester, Hui Zhao, Mesfin Gewe, Thomas Adame, Lisa Perruzza, David T Bolick, Jan Agosti, Nhi Khuong, Rolf Kuestner, Caitlin Gamble and 35 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors.

Benjamin W JesterLumen Bioscience, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-2997-7865
Hui ZhaoLumen Bioscience, Seattle, WA, USA.
Mesfin GeweLumen Bioscience, Seattle, WA, USA.
Thomas AdameLumen Bioscience, Seattle, WA, USA.
Lisa PerruzzaInstitute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona, Switzerland.
David T BolickDivision of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, VA, USA.
Jan AgostiLumen Bioscience, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-4952-3297
Nhi KhuongLumen Bioscience, Seattle, WA, USA.
Rolf KuestnerLumen Bioscience, Seattle, WA, USA.
Caitlin GambleLumen Bioscience, Seattle, WA, USA.
Kendra CruickshankLumen Bioscience, Seattle, WA, USA.
Jeremy FerraraLumen Bioscience, Seattle, WA, USA.
Rachelle LimLumen Bioscience, Seattle, WA, USA.
Troy PaddockLumen Bioscience, Seattle, WA, USA.
Colin BradyLumen Bioscience, Seattle, WA, USA.
Stacey ErtelLumen Bioscience, Seattle, WA, USA.
Miaohua ZhangLumen Bioscience, Seattle, WA, USA.
Alex PollockLumen Bioscience, Seattle, WA, USA.
Jamie LeeLumen Bioscience, Seattle, WA, USA.
Jian XiongDepartment of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA.
Michael TaschLumen Bioscience, Seattle, WA, USA.
Tracy SaveriaLumen Bioscience, Seattle, WA, USA.
David DoughtyLumen Bioscience, Seattle, WA, USA.
Jacob MarshallLumen Bioscience, Seattle, WA, USA.
Damian CarrieriLumen Bioscience, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-3978-299X
Lauren GoetschLumen Bioscience, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-4026-3107
Jason DangLumen Bioscience, Seattle, WA, USA.
Nathaniel SanjayaLumen Bioscience, Seattle, WA, USA.
David FletcherLumen Bioscience, Seattle, WA, USA.
Anissa MartinezLumen Bioscience, Seattle, WA, USA.
Bryce KadisLumen Bioscience, Seattle, WA, USA.
Kristjan SigmarLumen Bioscience, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-0717-7496
Esha AfreenLumen Bioscience, Seattle, WA, USA.
Tammy NguyenLumen Bioscience, Seattle, WA, USA.
Amanda RandolphLumen Bioscience, Seattle, WA, USA.
Alexandria TaberLumen Bioscience, Seattle, WA, USA.
Ashley KrzeszowskiLumen Bioscience, Seattle, WA, USA.
Brittney RobinettLumen Bioscience, Seattle, WA, USA.
David B VolkinDepartment of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA.
Fabio GrassiInstitute for Research in Biomedicine, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Bellinzona, Switzerland.ORCID http://orcid.org/0000-0003-3348-1712
Richard GuerrantDivision of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, VA, USA.
Ryo TakeuchiLumen Bioscience, Seattle, WA, USA.
Brian FinrowLumen Bioscience, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-7527-9307
Craig BehnkeLumen Bioscience, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-6949-7957
James RobertsLumen Bioscience, Seattle, WA, USA. jroberts@lumen.bio.ORCID http://orcid.org/0000-0003-3919-6760

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) OPP1183646Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) OPP12111977
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35440781
PMCPMC9200629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.